The in vitro behaviour of canine osteoblasts derived from different bone types.
Canine
Cortical
Femur
Osteoblast
Subchondral
Trabecular
Journal
BMC veterinary research
ISSN: 1746-6148
Titre abrégé: BMC Vet Res
Pays: England
ID NLM: 101249759
Informations de publication
Date de publication:
11 Apr 2019
11 Apr 2019
Historique:
received:
19
10
2018
accepted:
28
03
2019
entrez:
13
4
2019
pubmed:
13
4
2019
medline:
30
4
2019
Statut:
epublish
Résumé
Our understanding of the biology of osteoblasts is important as they underpin bone remodelling, fracture healing and processes such as osseointegration. Osteoblasts isolated from human humeral samples display distinctive biological activity in vitro, which relates to the samples' bone types (subchondral (S), trabecular (T), cortical (C)). Our aim was to isolate primary osteoblast cultures from different bone types from the proximal femur of a clinical population of dogs presented for total hip replacement and compare the behaviour of the osteoblasts derived from different bone types, to identify a preferred bone type for isolation. No differences were found for osteoblast doubling time (median for S = 2.9, T = 3.1 and C = 2.71 days, respectively; p = 0.33), final cell number (median for S = 54,849, T = 49,733, C = 61,390 cells/cm There is no significant difference in mean doubling time, basal or mineralizing TNAP activity or mineralized area in osteoblasts derived from subchondral, cortical, or trabecular bone types from the canine femoral head. However, there appears to be a high level of inter-animal variability in the studied parameters, which was independent of age, body mass, and sex. Trabecular isolate osteoblasts have the least variation of the bone types studied, and therefore should be considered a preferred source for primary osteoblast cultures. The work here provides baselines for canine osteoblast function, which has utility for future comparative studies.
Sections du résumé
BACKGROUND
BACKGROUND
Our understanding of the biology of osteoblasts is important as they underpin bone remodelling, fracture healing and processes such as osseointegration. Osteoblasts isolated from human humeral samples display distinctive biological activity in vitro, which relates to the samples' bone types (subchondral (S), trabecular (T), cortical (C)). Our aim was to isolate primary osteoblast cultures from different bone types from the proximal femur of a clinical population of dogs presented for total hip replacement and compare the behaviour of the osteoblasts derived from different bone types, to identify a preferred bone type for isolation.
RESULTS
RESULTS
No differences were found for osteoblast doubling time (median for S = 2.9, T = 3.1 and C = 2.71 days, respectively; p = 0.33), final cell number (median for S = 54,849, T = 49,733, C = 61,390 cells/cm
CONCLUSIONS
CONCLUSIONS
There is no significant difference in mean doubling time, basal or mineralizing TNAP activity or mineralized area in osteoblasts derived from subchondral, cortical, or trabecular bone types from the canine femoral head. However, there appears to be a high level of inter-animal variability in the studied parameters, which was independent of age, body mass, and sex. Trabecular isolate osteoblasts have the least variation of the bone types studied, and therefore should be considered a preferred source for primary osteoblast cultures. The work here provides baselines for canine osteoblast function, which has utility for future comparative studies.
Identifiants
pubmed: 30975149
doi: 10.1186/s12917-019-1857-1
pii: 10.1186/s12917-019-1857-1
pmc: PMC6460523
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
114Subventions
Organisme : Petplan Charitable Trust
ID : S14-40
Organisme : Leverhulme Trust (GB)
ID : RPG-2014-350
Références
J Shoulder Elbow Surg. 2000 Sep-Oct;9(5):409-17
pubmed: 11075325
Acta Orthop Scand. 1975 May;46(2):256-68
pubmed: 1146518
J Orthop Res. 2002 May;20(3):439-46
pubmed: 12038616
Vet J. 2002 May;163(3):240-50
pubmed: 12090766
Orthod Craniofac Res. 2003;6 Suppl 1:163-7; discussion 179-82
pubmed: 14606551
J Bone Joint Surg Br. 2005 Jan;87(1):120-7
pubmed: 15686252
J Musculoskelet Neuronal Interact. 2001 Jun;1(4):333-45
pubmed: 15758484
Osteoarthritis Cartilage. 2005 Apr;13(4):310-7
pubmed: 15780644
Biochem Biophys Res Commun. 2006 Sep 29;348(3):1082-8
pubmed: 16904067
J Musculoskelet Neuronal Interact. 2006 Oct-Dec;6(4):354
pubmed: 17185821
BMC Musculoskelet Disord. 2007 Aug 01;8:72
pubmed: 17678534
J Bone Joint Surg Am. 2008 Feb;90 Suppl 1:79-84
pubmed: 18292361
J Bone Joint Surg Br. 2008 May;90(5):680-4
pubmed: 18450641
Rheumatology (Oxford). 2010 Jun;49(6):1030-9
pubmed: 20176567
Endocrinology. 2010 Nov;151(11):5103-13
pubmed: 20844009
J Cell Sci. 2011 Apr 1;124(Pt 7):991-8
pubmed: 21402872
Eur Cell Mater. 2012 Jul 09;24:1-17
pubmed: 22777949
J Biol Chem. 2012 Aug 24;287(35):29851-60
pubmed: 22782898
Eur Cell Mater. 2012 Sep 24;24:278-91
pubmed: 23007912
Nat Rev Cancer. 2014 Nov;14(11):722-35
pubmed: 25319867
Bonekey Rep. 2014 Nov 12;3:585
pubmed: 25396049
Eur Cell Mater. 2015 Mar 04;29:155-75; discussion 175-6
pubmed: 25738584
J Exp Orthop. 2016 Dec;3(1):17
pubmed: 27525982
J Cell Physiol. 2017 Nov;232(11):2957-2963
pubmed: 28425564
Nature. 1972 Apr 7;236(5345):314-5
pubmed: 4111159
J Biomech. 1984;17(12):907-21
pubmed: 6520139
Anat Rec. 1982 May;203(1):31-45
pubmed: 7103125
Iowa Orthop J. 1995;15:118-40
pubmed: 7634023
FASEB J. 1995 Dec;9(15):1614-22
pubmed: 8529841
Endocrinology. 1998 Feb;139(2):663-70
pubmed: 9449639
J Endocrinol. 1997 Dec;155(3):411-21
pubmed: 9487986
Acta Orthop Scand. 1998 Aug;69(4):426-32
pubmed: 9798456